An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

计划入组 6,750 人 · 首次发布于 2012 年 1 月 18 日

Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma

计划入组 93,600,000 人 · 首次发布于 2026 年 7 月 20 日

Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma

首次发布于 2007 年 4 月 30 日

Thyroid, porcine

Armour Thyroid

thyroid hormone

Rare Thyroid Therapeutics International AB

Sweden

Veracyte

United States

AbbVie CDR (CAD Hedged)

United States

Immunotherapy Combination Shows Promise in Anaplastic Thyroid Carcinoma

ESTEVE Acquires Caprelsa Rights from Sanofi to Expand Rare Cancer Treatment Portfolio

Nivolumab and Ipilimumab Show Promise in Aggressive Thyroid Carcinoma Subtypes